Yes, magma13 has been examined by the National Institute of Biostructures and Biosystems (INBB – Interuniversity Consortium) at the Research Area of the National Research Council (CNR) by a team led by Prof. Carlo Ventura. Magma13 has shown to improve cell regeneration, increase the resistance of cells to environmental changes, have anti-inflammatory effects, and promote anti-aging factors. The research was conducted as part of a preliminary study on the effects of magma13 on somatic cells and human mesenchymal stem cells. Research continues with the aim of further exploring the mechanisms of the observed effects, as well as replicating the study. The results of this study have not yet been submitted for review by medical or public health authorities.

Condividi


Contact us

Leave your contact details and your request or contact us by e-mail info@propa.care or by phone +39.011.9507765